Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance

Lupus

Volumn 17, Issue 4, 2008, Pages 289-294

  Vargas Rojas, M I ^a   Crispin J C ^a   Richaud Patin, Y ^a   Alcocer Varela, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Regulatory T cells; Suppression; Systemic lupus erythematosus

Indexed keywords

CD4 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES, REGULATORY;

EID: 43249122144     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307088307     Document Type: Article

References (25)

1. Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562.
2. Picca, CC, Larkin, J, Boesteanu, A, Lerman, MA, Rankin, AL, Caton, AJ. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol Rev 2006; 212: 74-85.
3. Nishikawa, H, Kato, T, Tawara, I, et al. Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells. J Exp Med 2005; 201: 681-686.
4. Shevach, EM. Certified professionals: CD4+CD25+ suppressor T cells. J Exp Med 2001; 193: 41-46.
5. Fontenot, JD, Rasmussen, JP, Williams, LM, Dooley Farr, AG, Rudensky, AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005; 22: 329-341.
6. Hori, S, Nomura, T, Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
7. Owen, CJ, Jennings, CE, Imrie, H, et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab 2003; 88: 6034-6039.
8. Crispin, JC, Martínez, A, Alcocer-Varela, J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmunity 2003; 3: 273-276.
9. Liu, MF, Wang, CR, Fung, LL, Wu, CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004; 59: 198-202.
10. Miyara, M, Amoura, Z, Parizot, C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005; 175: 8392-8400.
11. Lee, JH, Wang, LC, Lin, YT, Yang, YH, Lin, DT, Chiang, BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006; 117: 280-286.
12. Baecher-Allan, C, Brown, JA, Freeman, GJ, Hafler, DA. CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
13. Ehrenstein, MR, Evans, JG, Singh, A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277-285.
14. Kriegel, MA, Lohman, T, Gabler, C, Blank, N, Kalden, JR, Lorenz, HM. Defective suppressor function of human CD4+CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004; 199: 1285-1291.
15. Viglietta, V, Baecher-Allan, C, Weiner, HL, Hafler, DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
16. Balandina, A, Lécart, S, Dartevelle, P, Saoudi, A, Berrih-Aknin, S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune mysthenia gravis. Blood 2005; 105: 735-741.
17. Monk, CR, Spachidou, M, Rovis, F, et al. MRL/Mp CD4+CD25- T cells show reduced sensitivity to suppression by CD4+CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1180-1184.
18. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Guzmán, J, Cardiel, MH, Arce-Salinas, A, Sánchez-Guerrero, J, Alarcón-Segovia, D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551-1558.
20. Hori, S, Takahashi, T, Sakaguchi, S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 2003; 81: 331-371.
21. Sakaguchi, S, Sakaguchi, N, Itoh, M, Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
22. Crispín, JC, Martínez, A, de Pablo, P, Velasquillo, C, Alcocer-Varela, J. Participation of the CD69 antigen in the T-Cell activation process of patients with systemic lupus erythematosus. Scand J Immunol 1998; 48: 196-200.
23. + T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis. Ann Rheum Dis, Aug 2007; doi: 10.1136/ard.2007.074690.
24. Kyttaris, VC, Tsokos, GC. T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2004; 16: 548-552.
25. +CD25 high T regulatory cells function in patient with active systemic lupus erythematosus. J Immunol 2007; 178: 2579-2588.